Related references
Note: Only part of the references are listed.Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells
Mingzhen Zhang et al.
BIOMATERIALS (2014)
Targeted therapy of brain ischaemia using Fas ligand antibody conjugated PEG-lipid nanoparticles
Ying-mei Lu et al.
BIOMATERIALS (2014)
Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
Neha Shrestha et al.
BIOMATERIALS (2014)
Augmented cellular trafficking and endosomal escape of porous silicon nanoparticles via zwitterionic bilayer polymer surface engineering
Mohammad-Ali Shahbazi et al.
BIOMATERIALS (2014)
Development of immunomonitoring of antibody-dependent cellular cytotoxicity against neuroblastoma cells using whole blood
Ferdousi Chowdhury et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Porous Silicon-Cell Penetrating Peptide Hybrid Nanocarrier for Intracellular Delivery of Oligonucleotides
Jussi Rytkonen et al.
MOLECULAR PHARMACEUTICS (2014)
Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA
Jianan Shen et al.
MOLECULAR PHARMACEUTICS (2014)
Poly(methyl vinyl ether-alt-maleic acid)-Functionalized Porous Silicon Nanoparticles for Enhanced Stability and Cellular Internalization
Mohammad-Ali Shahbazi et al.
MACROMOLECULAR RAPID COMMUNICATIONS (2014)
Assessing the In Vivo Targeting Efficiency of Multifunctional Nanoconstructs Bearing Antibody-Derived Ligands
Luisa Fiandra et al.
ACS NANO (2013)
Anti-CD30 antibody conjugated liposomal doxorubicin with significantly improved therapeutic efficacy against anaplastic large cell lymphoma
Ommoleila Molavi et al.
BIOMATERIALS (2013)
The mechanisms of surface chemistry effects of mesoporous silicon nanoparticles on immunotoxicity and biocompatibility
Mohammad-Ali Shahbazi et al.
BIOMATERIALS (2013)
Nanostructured porous silicon in preclinical imaging: Moving from bench to bedside
Helder A. Santos et al.
JOURNAL OF MATERIALS RESEARCH (2013)
Development of drug loaded nanoparticles for tumor targeting. Part 1: synthesis, characterization, and biological evaluation in 2D cell cultures
Mohammad H. El-Dakdouki et al.
NANOSCALE (2013)
Multistage Vectored siRNA Targeting Ataxia-Telangiectasia Mutated for Breast Cancer Therapy
Rong Xu et al.
SMALL (2013)
Antibody-Functionalized Porous Silicon Nanoparticles for Vectorization of Hydrophobic Drugs
Emilie Secret et al.
ADVANCED HEALTHCARE MATERIALS (2013)
Ambient temperature synthesis of citrate stabilized and biofunctionalized, fluorescent calcium fluoride nanocrystals for targeted labeling of cancer cells
Sisini Sasidharan et al.
BIOMATERIALS SCIENCE (2013)
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
Ursula J. E. Seidel et al.
FRONTIERS IN IMMUNOLOGY (2013)
Recent advances in porous silicon technology for drug delivery
Timothy J. Barnes et al.
THERAPEUTIC DELIVERY (2013)
Multivalent Porous Silicon Nanoparticles Enhance the Immune Activation Potency of Agonistic CD40 Antibody
Luo Gu et al.
ADVANCED MATERIALS (2012)
Quantitative control of targeting effect of anticancer drugs formulated by ligand-conjugated nanoparticles of biodegradable copolymer blend
Jing Zhao et al.
BIOMATERIALS (2012)
Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines
Agnieszka Martowicz et al.
BMC CANCER (2012)
Functionalized mesoporous silicon for targeted-drug-delivery
Ozra Tabasi et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
Analysis on the current status of targeted drug delivery to tumors
Il Keun Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Targeted drug delivery for cancer therapy: the other side of antibodies
Michael A. Firer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Thermally promoted addition of undecylenic acid on thermally hydrocarbonized porous silicon optical reflectors
Tero Jalkanen et al.
NANOSCALE RESEARCH LETTERS (2012)
Noncovalent Functionalization of Carbon Nanovectors with an Antibody Enables Targeted Drug Delivery
Jacob M. Berlin et al.
ACS NANO (2011)
EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy Preface
Hiroshi Maeda et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates
In-Hyun Lee et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Cetuximab-labeled liposomes containing near-infrared probe for in vivo imaging
Emma Portnoy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Investigating the structural biofunctionality of antibodies conjugated to magnetic nanoparticles
Emanuela Occhipinti et al.
NANOSCALE (2011)
Antibody Covalent Immobilization on Carbon Nanotubes and Assessment of Antigen Binding
Enrica Venturelli et al.
SMALL (2011)
Synthesis of Biomolecule-Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells
Daniel P. Ferris et al.
SMALL (2011)
In vitro cytotoxicity of porous silicon microparticles: Effect of the particle concentration, surface chemistry and size
Helder A. Santos et al.
ACTA BIOMATERIALIA (2010)
A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery
Yutao Liu et al.
BIOMATERIALS (2010)
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Monoclonal antibodies for cancer immunotherapy
Louis M. Weiner et al.
LANCET (2009)
Active targeting schemes for nanoparticle systems in cancer therapeutics
James D. Byrne et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
A mechanistic perspective of monoclonal antibodies in cancer therapy beyond target-related effects
Scott E. Strome et al.
ONCOLOGIST (2007)
Fourier transform infrared spectroscopic analysis of protein secondary structures
Jilie Kong et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)
Cetuximab induce antibody-dependent cellular cytotoxicity against EGFR-expressing esophageal squamous cell carcinoma
Yoshihiko Kawaguchi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Combined chemoimmunotherapy of solid tumours: Improving vaccines?
Anna K. Nowak et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies
A Iannello et al.
CANCER AND METASTASIS REVIEWS (2005)
FcγR polymorphisms:: Implications for function, disease susceptibility and immunotherapy
NM van Sorge et al.
TISSUE ANTIGENS (2003)
The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology
MJ Winter et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Share Paper
